BriaCell Therapeutics Corp.

BCT.TOTSXHealthcare● Active

$4.28

$-0.03(-0.70%)

Market Cap$8062411

P/E Ratio—

52W High$49

52W Low$4.13

Avg Volume15K

Open$4.31

Beta1.64

Cash on Hand Financials Revenue

BriaCell Therapeutics Corp. (BCT.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BCT.TO · cash on hand · updated Jul 31, 2025

Core cash position

as of Jul 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$17.9M▲ +1979.5% vs prior year

FY · as of Jul 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$10.5M

cashAndCashEquivalents

Short-Term Investments

$7.4M

shortTermInvestments

YoY Change vs Prior Year

+1979.5%

vs prior fiscal year

Latest Quarter

$29.7M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: July 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$17.9MCash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$17.9MNet Cash Position

Cash vs Debt Ratio

Cash 100%BriaCell Therapeutics Corp. cash as % of market cap: 222.36%% · MCap $0BDebt 0%

BriaCell Therapeutics Corp. has a net cash position of $17.9M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$17.9M − $0 = +$17.9M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

BCT.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

BCT.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Jul 31, 2025LatestFY$17.9M+1979.5%

Jul 31, 2024FY$0.9M-95.9%

Jul 31, 2023FY$21.3M-48.2%

Jul 31, 2022FY$41.0M-28.3%

Jul 31, 2021FY$57.3M+219429.6%

BCT.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

BCT.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

BriaCell Therapeutics Corp.YOU

BCT.TO

$17.9M$8M222.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

BriaCell Therapeutics Corp. (BCT.TO) cash on hand as of July 31, 2025 is $17.9M, comprising $10.5M in cash and cash equivalents (CCE) plus $7.4M in short-term investments — reported as BriaCell Therapeutics Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as BriaCell Therapeutics Corp. cash reserves or cash position.

BriaCell Therapeutics Corp. annual cash on hand history shows increased +1979.5% in 2025: increased +1979.5% in 2025. BriaCell Therapeutics Corp. cash reserves in 2025 reflect the company's capital allocation strategy.

BriaCell Therapeutics Corp. carries total debt of $0 against cash of $17.9M, resulting in a net cash position of +$17.9M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

BCT.TO cash on hand · 5 questions

As of July 31, 2025, BriaCell Therapeutics Corp. (BCT.TO) has $17,927,510 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $10,529,771 in cash and cash equivalents (CCE) plus $7,397,739 in short-term investments. Latest quarter (January 31, 2026): $29,653,754. Data sourced from the annual 10-K filing via FMP.

BCT.TO cash on handBCT.TO cash reservesBCT.TO cash 2025how much cash does BCT.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · BriaCell Therapeutics Corp. · BriaCell Therapeutics Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: July 31, 2025